Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease

Clinica Chimica Acta

Volumn 373, Issue 1-2, 2006, Pages 77-81

  Sarkar, Purnima Dey ^a   T M , Shivaprakash ^b   Madhusudhan, Basavaraj ^c  

^a MGM MEDICAL COLLEGE   (India)

^b Devi Ahalya Vishwavidyalaya ^*  (India)

^c KUVEMPU UNIVERSITY   (India)

Author keywords

Coronary artery disease; Lipoproteins; Paraoxonase; Risk factors

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOGRAPHY; ARTICLE; ASIAN; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SMOKING; SOUTH ASIA; STATISTICAL SIGNIFICANCE;

ADULT; AGE OF ONSET; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INDIA; LINEAR MODELS; LIPOPROTEINS; MALE; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RISK FACTORS;

EID: 33748164019     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.005     Document Type: Article

References (42)

1. Reddy K.S. Cardiovascular disease in India. World Health Stat 46 (1993) 101-107
2. Gupta V.P., and Gupta R. Meta-analysis of coronary heart disease prevalence in Indian. Indian Heart J 48 (1996) 241-245
3. Kaul U., Manchanda S.C., and Bhatia M.L. Myocardial infarction in young Indian patients, risk factors and angiographic profile. Am Heart J 71 (1986) 112-115
4. Pahlajani D.B., and Chawal M.H. Coronary artery disease pattern in ice young. JAPI 37 5 (1989) 312-315
5. La Du B.N. Human serum paraoxonase/arylesterase. In: Kalow W. (Ed). Pharmacogenetics of Drug Metabolism (1992), NY: Pergamon Press, New York 51-91
6. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., and Hegele R.A. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7 (1996) 69-76
7. Primo-Parma S.I., Sorenson R.C., Teiber J., and La Du B.N. The human serum paraoxonase/arylesterase gene (P.N1) is one member of a multigene family. Genomics 33 (1996) 498-509
8. Parthasarathy S., Barnett J., and Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044 (1990) 275-283
9. Klimov A.N., Kozhemyakin L.A., Pleskov V.M., and Andrerva L.I. Antioxidative effect of high-density lipoproteins in the oxidation of low-density lipoproteins. Bull Exp Biol Med (Russ) 103 (1987) 550-552
10. Mackness M.I., Abbott C.A., Arrd S., and Durrington P.N. The role of high-density lipoprotein and lipid soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294 (1993) 829-834
11. Navab M., Imes S.S., Hama S.Y., et al. Monocyte transmigration induced by modification of LDL in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein/synthesis and is abolished by high-density lipoprotein. J Clin Invest 88 (1991) 2039-2046
12. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
13. Mackness M.I., and Durrington P.N. High-density lipoprotein, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115 (1995) 243-253
14. Mackness M.I., Harty D., Bhatnagar D., et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis 86 (1991) 193-198
15. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J., and Durrington P.N. Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15 (1995) 1812-1818
16. Ruiz J., Blanche H., James R.W., et al. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346 (1995) 869-872
17. Serrato M., and Marian A.J. A variant of human PON/arylesterase gene (HUMPONA) is a risk factor for coronary artery disease. J Clin Invest 96 (1995) 3005-3008
18. Sanghera D.K., Saha N., Aston C.E., and Kamboh M.I. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 17 (1997) 1067-1073
19. Pati N., and Pati U. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects. Int J Cardiol 66 (1998) 165-168
20. Odawara M., Tachi Y., and Yamashita K. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82 (1997) 2257-2260
21. Imai Y., Marita H., Kurihora H., et al. Evidence for association between paraoxonase gene polymorphism and atherosclerotic diseases. Atherosclerosis 149 (2000) 435-442
22. Pfohl M., Koch M., Euderle M.D., et al. Paraoxonase 192 Glu/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 48 (1999) 623-627
23. Zama T., Murala M., Matsubara Y., et al. A 192-Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 17 (1997) 3565-3569
24. Bhatnagar D., Anand I.S., Durrington P.N., et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 345 (1995) 405-409
25. Tewari S., kumar S., kapoor A., et al. Premature CAD in North India: an angiography study of 1971 patients. Indian Heart J 57 (2005) 311-318
26. Lo Rosa J.C. The cholesterol facts. A joint statement by the Am Heart Assoc and NHLBI. Circulation 81 (1990) 1721-1733
27. Uhl G.S., and Farrell P.W. Myocardial infarction in young adults: risk factors and natural history. Am Heart J 105 (1983) 548-553
28. Gupta S.R., Gupta S.K., Reddy K.N., et al. Coronary artery disease in young Indian adults. Indian Heart J 39 (1987) 284-287
29. Pais P., Pogue J., Gerstein H., et al. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 348 (1996) 358-363
30. Chen L., Chester M., and Kaski J.C. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108 (1995) 364-369
31. Zimmerman F.H., Cameron A., Fisher L.D., et al. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis. J Am Coll Cardiol 26 (1995) 654-661
32. Mackness B., Davis G.K., Turkie W., et al. Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype?. Arterioscler Thromb Vasc Biol 21 (2001) 1451-1457
33. Shih D.M., Gu L., Hama S., et al. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 97 (1996) 1630-1639
34. Rahamani M., Raiszadeh F., Allahverdian S., Motamedi M.R., and Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein A-1/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Irn J Endocrinol Metab 2 1 (2000) 5
35. Liu K., Cuddy T.E., and Pierce G.N. Oxidative status of lipoproteins in coronary disease patients. Am Heart J 123 (1992) 285-289
36. Regnstrom J., Nilsson J., Toruvall P., Laudou C., and Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1183-1185
37. Salonen J.T., Yla-Herttuala S., Yamamotto R., and Butler S. Autoantibody against oxidized ALDL and progression of carotid atherosclerosis. Lancet 339 (1992) 883-886
38. Navab M., Hama S.Y., Van Lanten B.J., et al. Mildly oxidized LDL induces an increased apolipoprotein j/paraoxonase ratio. J Clin Invest 99 (1997) 2005-2019
39. Mackness M.I. 'A'-esterases: enzymes looking for a role?. Biochem Pharmacol 38 (1989) 385-390
40. Mackness M.I., Bouiller A., Hennuyer M., et al. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun 269 (2000) 232-236
41. Sutherland W.H.F., Walker R.J., de Jong S.A., Van Rij A.M., Phillips V., and Walker H.L. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 19 (1999) 1340-1347
42. Van der Gaag M.S., Van Tol A., Scheek L.M., et al. Daily moderate alcohol consumption increases serum paraoxonase activity: a diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis 147 (1999) 405-410